Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Billionaire Marc Lasry’s Favorite Stock Picks: Meritor Inc. (MTOR), Gener8 Maritime Inc (GNRT) & More

Page 1 of 2

Marc Lasry is the co-founder of Avenue Capital, which was launched with $7 million in funding from friends and family in 1995, and currently holds the CEO position. Lasry has also invested in Milwaukee Bucks and partnered with Fortress’ Wesley Eden to acquire the NBA team in May 2014 for $550 million. Avenue Capital focuses distressed and undervalued debt and equity opportunities in the U.S., Asia and Europe. It also focuses on real estate and securitized loan obligation.

The equity value of Avenue Capital’s portfolio stood at $427.20 million at the end of the second quarter. According to the fund’s 13F filing for the quarter, transportation stocks accounted for 29% of the portfolio followed by Utilities & telecommunication stocks, which amassed 27%, while consumer discretionary stocks represented 25% at the end of June. In this article, we will take a look at Avenue Capital’s favorite stock picks, in which the fund held the largest positions heading into the third quarter.

Through extensive research, we determined that imitating some of the picks of hedge funds and other institutional investors can help generate market-beating returns over the long run. The key is to focus on the small-cap picks of these investors, since they are usually less followed by the broader market and are less price-efficient. Our backtests that covered the period between 1999 and 2012, showed that following the 15 most popular small-caps among hedge funds can help a retail investor beat the market by an average of 95 basis points per month (see more details here).


Meritor Inc. (NYSE:MTOR) was Avenue Capital’s second-largest position in the consumer discretionary space, accounting for 8.18% of the total portfolio at the end of June quarter. The fund held 4.85 million shares valued at $34.93 million at the end of June. Among the funds we track, 18 were long the stock at the end of the second quarter, unchanged over the quarter, while the total value of their holdings declined to $164.91 million from $189.15 million and represented 25.70% of the outstanding shares at the end of June. Meritor Inc. (NYSE:MTOR) reported third-quarter earnings of $0.57 per share, beating the estimates of $0.43 per share, while revenue declined by 7.5% on the year to $841 million and topped the expectations by $2.45 million.

Follow Meritor Inc (NYSE:MTOR)
Trade (NYSE:MTOR) Now!

Avenue Capital held 7.21 million shares of Gener8 Maritime Inc (NYSE:GNRT) at the end of the second quarter, the value of which stood at $46.16 million and amassed 10.81% of the total portfolio. The hedge fund did not made any additions to its position during the quarter. Gener8 Maritime had 17 funds from our database long its stock at the end of the second quarter, holding $269.65 million worth of shares, which accounted for 51% of the company’s float. A quarter earlier, 20 funds held positions worth $299.63 million in aggregate. Gener8 Maritime Inc (NYSE:GNRT) recently announced that it took the delivery of two “ECO” VLCCs, the Gener8 Perseus on September 9 and the Gener8 Oceanus on September 12 from Hyundai Heavy Industries Co., Ltd and Hyundai Samho Heavy Industries Co., Ltd., respectively. With this delivery, the company now has 15 “ECO” VLCCs in its fleet.

Follow Gener8 Maritime Inc. (NYSE:GNRT)
Trade (NYSE:GNRT) Now!

Read about Avenue Capital’s three other favorite stock picks on the next page.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!